Search results for "Vaccines"
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/01/latest-updates-on-acps-priorities-initiatives.htm
1 Jan 2024
Looking ahead at the past
ACP membership inspires through its principles, opportunities, and relevance.
https://immattersacp.org/archives/2024/01/looking-ahead-at-the-past.htm
1 Jan 2024
Tirzepatide for weight management, at-home STI tests
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024
Recombinant flu vaccine appears to provide benefit in patients ages 50 to 64 years
An industry-funded study compared a high-dose recombinant influenza vaccine with one of two standard-dose egg-based vaccines over two flu seasons and found patients who received a high-dose vaccine were less likely to test positive for flu.
https://immattersacp.org/weekly/archives/2023/12/19/2.htm
19 Dec 2023
Modeling study finds RSV vaccines cost-effective for older U.S. adults
Vaccination programs using the monovalent adjuvanted or bivalent vaccine against respiratory syncytial virus (RSV) were projected to be potentially cost-effective at a price per dose of up to $127 or up to $118, respectively, over a first RSV season.
https://immattersacp.org/weekly/archives/2023/12/05/4.htm
5 Dec 2023
ACP urges adults to get their influenza vaccine during National Influenza Vaccination Week
ACP is urging all adults to get vaccinated as influenza season, holiday gatherings, and winter weather are here, along with the continued presence of COVID-19 and respiratory syncytial virus.
https://immattersacp.org/weekly/archives/2023/12/05/5.htm
5 Dec 2023
MKSAP Quiz: Evaluation for multiple myeloma
A 64-year-old man is evaluated following a recent diagnosis of multiple myeloma. Chemotherapy is planned to begin in 14 days. Which prophylactic therapy is indicated today?
https://immattersacp.org/weekly/archives/2023/12/05/3.htm
5 Dec 2023
New findings on antiviral flu treatment
A recent study raises doubts about whether oseltamivir should be promoted as a way to prevent hospitalization in low-risk patients.
https://immattersacp.org/archives/2023/11/new-findings-on-antiviral-flu-treatment.htm
1 Nov 2023
New COVID-19 boosters, DNA test for cancer risk OK’ed
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/11/new-covid-19-boosters-dna-test-for-cancer-risk-oked.htm
1 Nov 2023
RSV vaccines new tool for physicians
The CDC's Advisory Committee on Immunization Practices recommended in June that adults ages 60 years and older may receive a single dose of an RSV vaccine, using shared clinical decision making.
https://immattersacp.org/archives/2023/10/rsv-vaccines-new-tool-for-physicians.htm
1 Oct 2023